Nexalin says Carolyn Shelton exits senior vice president role
Nexalin said Carolyn Shelton departed as Senior Vice President of Quality, Regulatory and Clinical Affairs, effective August 28, 2026, under a separation agreement covering bonus and option vesting.
Nexalin announced the departure of Carolyn Shelton as Senior Vice President of Quality, Regulatory, and Clinical Affairs, effective August 28, 2026, and disclosed terms of a separation agreement.Original SEC Filing: Nexalin Technology, Inc. [ NXL ] - 8-K - Sep.
02, 2026This is an AI-powered summary…